# AnnotationID, ClassType, DocCharOnset(incl), DocCharOffset(excl), Text, Meta, Instances
0, Journal, 0, 13, "Ophthalmology", "", "<http://ctro/data#Publication_103060> <http://ctro/data#hasJournal> \"Ophthalmology\"."
1, PublicationYear, 16, 20, "1997", "", "<http://ctro/data#Publication_103060> <http://ctro/data#hasPublicationYear> \"1997\"."
4, Title, 51, 155, "A comparative study of two dose regimens of latanoprost in patients with elevated intraocular pressure .", "", "<http://ctro/data#Publication_103060> <http://ctro/data#hasTitle> \"A comparative study of two dose regimens of latanoprost in patients with elevated intraocular pressure .\"."
2, Latanoprost, 95, 106, "latanoprost", "", 
97, Precondition, 110, 153, "patients with elevated intraocular pressure", "", "<http://ctro/data#Population_103094> <http://ctro/data#hasPrecondition> \"patients with elevated intraocular pressure\"."
3, IOP, 133, 153, "intraocular pressure", "", 
5, Author, 156, 163, "Lusky M", "", "<http://ctro/data#Publication_103060> <http://ctro/data#hasAuthor> \"Lusky M\"."
6, Author, 172, 179, "Ticho U", "", "<http://ctro/data#Publication_103060> <http://ctro/data#hasAuthor> \"Ticho U\"."
7, Author, 182, 193, "Glovinsky J", "", "<http://ctro/data#Publication_103060> <http://ctro/data#hasAuthor> \"Glovinsky J\"."
8, Author, 196, 208, "Weinberger D", "", "<http://ctro/data#Publication_103060> <http://ctro/data#hasAuthor> \"Weinberger D\"."
9, Author, 211, 219, "Nesher R", "", "<http://ctro/data#Publication_103060> <http://ctro/data#hasAuthor> \"Nesher R\"."
10, Author, 222, 230, "Yassur Y", "", "<http://ctro/data#Publication_103060> <http://ctro/data#hasAuthor> \"Yassur Y\"."
11, Author, 233, 242, "Melamed S", "", "<http://ctro/data#Publication_103060> <http://ctro/data#hasAuthor> \"Melamed S\"."
12, Israel, 358, 364, "Israel", "", "<http://ctro/data#Population_103094> <http://ctro/data#hasCountry> <http://ctro/data#Israel>."
107, ObjectiveDescription, 379, 555, "The purpose of the study was to determine whether latanoprost ( 13 , 14 - dihydro - 17 - phenyl - 18 , 19 , 20 - trinor PGF2a - isopropyl ester ) , a new prostaglandin analogue", "", "<http://ctro/data#ClinicalTrial_103073> <http://ctro/data#hasObjectiveDescription> \"The purpose of the study was to determine whether latanoprost ( 13 , 14 - dihydro - 17 - phenyl - 18 , 19 , 20 - trinor PGF2a - isopropyl ester ) , a new prostaglandin analogue\"."
13, Latanoprost, 429, 440, "latanoprost", "", 
108, ObjectiveDescription, 556, 715, "that has been found effective in reducing intraocular pressure ( IOP ) in humans , is equally effective at lower concentrations than those currently employed .", "", "<http://ctro/data#ClinicalTrial_103073> <http://ctro/data#hasObjectiveDescription> \"that has been found effective in reducing intraocular pressure ( IOP ) in humans , is equally effective at lower concentrations than those currently employed .\"."
15, IOP, 598, 618, "intraocular pressure", "", 
16, IOP, 621, 624, "IOP", "", 
19, NumberPatientsCT, 742, 747, "Fifty", "", "<http://ctro/data#ClinicalTrial_103073> <http://ctro/data#hasNumberPatientsCT> \"Fifty\"."
106169, Precondition, 748, 793, "patients with glaucoma or ocular hypertension", "", "<http://ctro/data#Population_103094> <http://ctro/data#hasPrecondition> \"patients with glaucoma or ocular hypertension\"."
20, Glaucoma, 762, 770, "glaucoma", "", "<http://ctro/data#Glaucoma_103082> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Glaucoma>. <http://ctro/data#ClinicalTrial_103073> <http://ctro/data#analysesHealthCondition> <http://ctro/data#Glaucoma_103082>."
21, OcularHypertension, 774, 793, "ocular hypertension", "", "<http://ctro/data#ClinicalTrial_103073> <http://ctro/data#analysesHealthCondition> <http://ctro/data#OcularHypertension>."
22, Randomized, 812, 822, "randomized", "", "<http://ctro/data#ClinicalTrial_103073> <http://ctro/data#hasCTDesign> <http://ctro/data#Randomized>."
23, Crossover, 825, 834, "crossover", "", "<http://ctro/data#ClinicalTrial_103073> <http://ctro/data#hasCTDesign> <http://ctro/data#Crossover>."
24, DoubleBlind, 837, 852, "double - masked", "", "<http://ctro/data#ClinicalTrial_103073> <http://ctro/data#hasCTDesign> <http://ctro/data#DoubleBlind>."
25, DoseValue, 866, 867, "1", "", 
106170, DoseDescription, 866, 872, "1 drop", "", "<http://ctro/data#Medication_103801> <http://ctro/data#hasDoseDescription> \"1 drop\". <http://ctro/data#Medication_103808> <http://ctro/data#hasDoseDescription> \"1 drop\"."
27, Eyedrops, 868, 872, "drop", "", "<http://ctro/data#Medication_103801> <http://ctro/data#hasDeliveryMethod> <http://ctro/data#Eyedrops>. <http://ctro/data#Medication_103808> <http://ctro/data#hasDeliveryMethod> <http://ctro/data#Eyedrops>."
28, Latanoprost, 876, 887, "latanoprost", "", "<http://ctro/data#Latanoprost_103802> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Latanoprost>. <http://ctro/data#Medication_103801> <http://ctro/data#hasDrug> <http://ctro/data#Latanoprost_103802>. <http://ctro/data#Latanoprost_103809> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Latanoprost>. <http://ctro/data#Medication_103808> <http://ctro/data#hasDrug> <http://ctro/data#Latanoprost_103809>."
29, DoseValue, 890, 892, "50", "", "<http://ctro/data#Medication_103808> <http://ctro/data#hasDoseValue> \"50\"."
122, BioAndMedicalUnit, 893, 904, "microg / ml", "", "<http://ctro/data#BioAndMedicalUnit_103811> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#BioAndMedicalUnit>. <http://ctro/data#Medication_103808> <http://ctro/data#hasDoseUnit> <http://ctro/data#BioAndMedicalUnit_103811>."
32, Frequency, 905, 915, "once daily", "", "<http://ctro/data#Intervention_103789> <http://ctro/data#hasFrequency> \"once daily\"."
30, DoseValue, 920, 922, "15", "", "<http://ctro/data#Medication_103801> <http://ctro/data#hasDoseValue> \"15\"."
126, BioAndMedicalUnit, 923, 934, "microg / ml", "", "<http://ctro/data#BioAndMedicalUnit_103804> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#BioAndMedicalUnit>. <http://ctro/data#Medication_103801> <http://ctro/data#hasDoseUnit> <http://ctro/data#BioAndMedicalUnit_103804>."
31, Frequency, 935, 946, "twice daily", "", "<http://ctro/data#Intervention_103783> <http://ctro/data#hasFrequency> \"twice daily\"."
33, Duration, 979, 986, "3 weeks", "", "<http://ctro/data#ClinicalTrial_103073> <http://ctro/data#hasCTduration> \"3 weeks\"."
38, TimePoint, 1037, 1043, "8 : 00", "", 
37, TimePoint, 1046, 1053, "13 : 00", "", 
36, TimePoint, 1060, 1073, "17 : 00 hours", "", 
129, TimePoint, 1077, 1085, "baseline", "", 
130, TimePoint, 1110, 1117, "3 weeks", "", 
39, Placebo, 1142, 1149, "Placebo", "", "<http://ctro/data#Medication_103815> <http://ctro/data#hasDrug> <http://ctro/data#Placebo>."
40, Latanoprost, 1173, 1184, "latanoprost", "", 
41, Eyedrops, 1185, 1193, "eye drop", "", "<http://ctro/data#Medication_103815> <http://ctro/data#hasDeliveryMethod> <http://ctro/data#Eyedrops>."
42, Mean, 1259, 1263, "Mean", "", "<http://ctro/data#Mean_103105> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Mean>. <http://ctro/data#Endpoint_103103> <http://ctro/data#hasAggregationMethod> <http://ctro/data#Mean_103105>."
43, Diurnal_IOP, 1287, 1298, "diurnal IOP", "", "<http://ctro/data#Endpoint_103103> <http://ctro/data#hasEndoPointDescription> <http://ctro/data#Diurnal_IOP>."
44, BaseLineValue, 1325, 1331, "24 . 7", "", 
45, mmHg, 1332, 1336, "mmHg", "", "<http://ctro/data#Endpoint_103103> <http://ctro/data#hasBaselineUnit> <http://ctro/data#mmHg>."
46, IOP, 1339, 1359, "Intraocular pressure", "", 
47, Reduction, 1375, 1380, "6 . 1", "", "<http://ctro/data#Outcome_103822> <http://ctro/data#hasChangeValue> \"6 . 1\"."
49, mmHg, 1381, 1385, "mmHg", "", 
51, Latanoprost, 1391, 1402, "latanoprost", "", 
62, DoseValue, 1403, 1405, "15", "", 
148, BioAndMedicalUnit, 1406, 1417, "microg / ml", "", 
52, Frequency, 1418, 1429, "twice daily", "", 
48, Reduction, 1439, 1444, "7 . 5", "", "<http://ctro/data#Outcome_103849> <http://ctro/data#hasChangeValue> \"7 . 5\"."
50, mmHg, 1445, 1449, "mmHg", "", 
63, DoseValue, 1455, 1457, "50", "", 
149, BioAndMedicalUnit, 1458, 1469, "microg / ml", "", 
53, Frequency, 1470, 1480, "once daily", "", 
78, ObservedResult, 1483, 1526, "Results with both regimens were significant", "", "<http://ctro/data#Outcome_103822> <http://ctro/data#hasObservedResult> \"Results with both regimens were significant\". <http://ctro/data#Outcome_103849> <http://ctro/data#hasObservedResult> \"Results with both regimens were significant\"."
152, PValueResValue, 1529, 1545, "P & lt ; 0 . 001", "", "<http://ctro/data#Outcome_103822> <http://ctro/data#hasPValueResValue> \"P & lt ; 0 . 001\". <http://ctro/data#Outcome_103849> <http://ctro/data#hasPValueResValue> \"P & lt ; 0 . 001\"."
65, DoseValue, 1592, 1594, "50", "", 
161, BioAndMedicalUnit, 1595, 1606, "microg / ml", "", 
74, DoseValue, 1654, 1656, "15", "", 
162, BioAndMedicalUnit, 1657, 1668, "microg / ml", "", 
75, DiffGroupAbsValue, 1697, 1702, "1 . 4", "", "<http://ctro/data#DiffBetweenGroups_103876> <http://ctro/data#hasDiffGroupAbsValue> \"1 . 4\"."
76, mmHg, 1703, 1707, "mmHg", "", 
167, PvalueDiff, 1710, 1726, "P & lt ; 0 . 001", "", "<http://ctro/data#DiffBetweenGroups_103876> <http://ctro/data#hasPvalueDiff> \"P & lt ; 0 . 001\"."
106164, EndPointDescription, 1808, 1832, "mild , ocular discomfort", "", 
119892, ObservedResult, 1835, 1909, "The higher dose did not cause more hyperemia at 3 weeks than the lower one", "", "<http://ctro/data#Outcome_103890> <http://ctro/data#hasObservedResult> \"The higher dose did not cause more hyperemia at 3 weeks than the lower one\"."
80, ConjunctivalHyperemia, 1870, 1879, "hyperemia", "", "<http://ctro/data#Endpoint_103885> <http://ctro/data#hasEndoPointDescription> <http://ctro/data#ConjunctivalHyperemia>."
169, TimePoint, 1883, 1890, "3 weeks", "", "<http://ctro/data#Outcome_103890> <http://ctro/data#hasTimePoint> \"3 weeks\"."
170, PvalueDiff, 2013, 2028, "P & lt ; 0 . 29", "", 
83, Latanoprost, 2055, 2066, "Latanoprost", "", 
88, ConclusionComment, 2055, 2183, "Latanoprost administered at a concentration of 50 microg / ml once daily effectively reduces IOP in patients with elevated IOP .", "", "<http://ctro/data#ClinicalTrial_103073> <http://ctro/data#hasConclusionComment> \"Latanoprost administered at a concentration of 50 microg / ml once daily effectively reduces IOP in patients with elevated IOP .\"."
84, DoseValue, 2102, 2104, "50", "", 
163, BioAndMedicalUnit, 2105, 2116, "microg / ml", "", 
85, Frequency, 2117, 2127, "once daily", "", 
86, IOP, 2148, 2151, "IOP", "", 
87, IOP, 2178, 2181, "IOP", "", 
91, ConclusionComment, 2184, 2298, "Administration of a lower concentration ( 15 microg / ml ) twice daily is less effective , but still significant .", "", "<http://ctro/data#ClinicalTrial_103073> <http://ctro/data#hasConclusionComment> \"Administration of a lower concentration ( 15 microg / ml ) twice daily is less effective , but still significant .\"."
89, DoseValue, 2226, 2228, "15", "", 
164, BioAndMedicalUnit, 2229, 2240, "microg / ml", "", 
90, Frequency, 2243, 2254, "twice daily", "", 
92, PMID, 2354, 2361, "9331215", "", "<http://ctro/data#Publication_103060> <http://ctro/data#hasPMID> \"9331215\"."
